Systematic review: recurrent autoimmune liver diseases after liver transplantation

Summary Background Autoimmune liver diseases (AILD) constitute the third most common indication for liver transplantation (LT) worldwide. Outcomes post LT are generally good but recurrent disease is frequently observed. Aims To describe the frequency and risk factors associated with recurrent AILD p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2017-02, Vol.45 (4), p.485-500
Hauptverfasser:	Montano‐Loza, A. J., Bhanji, R. A., Wasilenko, S., Mason, A. L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Cholangitis Cholestasis Cirrhosis Clinical Trials as Topic - methods Colon Cyclosporine - therapeutic use Enzymes Explants Female Graft Survival Hepatitis Hepatitis, Autoimmune - diagnosis Hepatitis, Autoimmune - drug therapy Hepatitis, Autoimmune - epidemiology Humans Immunoglobulin G Immunosuppression Immunosuppression - methods Immunosuppression - trends Immunosuppressive Agents - therapeutic use Incidence Indication Inflammatory bowel diseases Intestine Liver Liver cirrhosis Liver Cirrhosis, Biliary - diagnosis Liver Cirrhosis, Biliary - drug therapy Liver Cirrhosis, Biliary - epidemiology Liver diseases Liver transplantation Liver Transplantation - adverse effects Liver Transplantation - trends Male Recurrence Risk factors Steroid hormones Steroids Steroids - therapeutic use Survival Rate - trends Tacrolimus Tacrolimus - therapeutic use Transplantation Ulcerative colitis Ursodeoxycholic acid Ursodeoxycholic Acid - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!